TAM
SAGE

Tyers Asset Management’s Sage Therapeutics SAGE Stock Holding History

Tyers Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$444K Hold
3,164
– – 0.01% 505
2019
Q2 		$579K Buy
3,164
+140
+5% +$23.9K 0.02% 445
2019
Q1 		$481K Buy
3,024
+392
+15% +$56.8K 0.02% 479
2018
Q4 		$252K Sell
2,632
-168
-6% -$19.2K 0.01% 605
2018
Q3 		$395K Buy
2,800
+2,240
+400% +$346K 0.01% 559
2018
Q2 		$88K Buy
560
+532
+1,900% +$83.5K ﹤0.01% 860
2018
Q1 		$4K Buy
+28
New +$4.75K ﹤0.01% 969

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Tyers Asset Management's SAGE Position: Q3 2019 in Review

Tyers Asset Management held its Sage Therapeutics (SAGE) position steady in Q3 2019 at 3,164 shares worth $444K. The position accounts for 0.01% of the portfolio, ranked #505.

Tyers Asset Management first reported a position in SAGE in Q1 2018 and has held it in 7 quarters since. The position peaked at $579K in Q2 2019. 284 funds tracked by Wall St. Rank hold SAGE as of Q3 2019.

  • Tyers Asset Management held 3,164 shares of Sage Therapeutics worth $444K as of Q3 2019.
  • Tyers Asset Management left its Sage Therapeutics share count unchanged in Q3 2019.
  • Sage Therapeutics made up 0.01% of Tyers Asset Management's portfolio in Q3 2019, its #505 holding.
  • Tyers Asset Management first reported a position in Sage Therapeutics in Q1 2018 and has held it in 7 quarters since.
  • Tyers Asset Management's Sage Therapeutics position peaked at $579K in Q2 2019.
  • 284 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.